A Study of MK-2060 in Healthy Participants (MK-2060-016)

Clinical trial NCT06582602 · COMPLETED

Trial details

NCT number: NCT06582602
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Venous Thrombosis

Start date: 2024-10-15
Primary completion: 2025-04-18
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.